Thesis
Slow skincare is a roadmap, not a slogan. It dictates what we ship, how often, and what we refuse to make. Three product lines in eighteen months, not twelve. Twelve-week trials before any internal verdict on a formula. No trend launches, no participation in the algorithm’s appetite. The discipline is the product.
I get asked, a few times a month, why we don’t launch more often. The honest answer is that I don’t believe most launches are useful. The skincare aisle is loud because the calendar demands it. Brands ship four times a year because retail buyers want newness, not because skin needs it. We started Elelaf with a quieter calendar on purpose.
What the roadmap actually says
Internally we keep a document that lists every product we have considered making. It has forty-three entries. Three of them shipped. The others sit there, dated, with notes explaining why we passed. Some were good ideas in a category that didn’t need another good idea. Some were ideas where we couldn’t formulate at the percentage we wanted at a price we could defend. Most were ideas that wouldn’t survive a twelve-week trial against the products we already ship.
The rule we landed on is that a new product has to either replace something in our customers’ routines or fill a slot nobody else is filling well. “Add to the stack” is not a reason to launch.
Why the calendar matters more than the formula
A formulator will tell you that any given hero ingredient can be in a serum within nine months if you push. The bottleneck is not chemistry. The bottleneck is testing it long enough to know whether you are shipping something good or something that just polls well in a four-week panel.
The skincare industry’s dirty secret is that almost no consumer testing happens past eight weeks. Most internal panels run four to six. Most consumer claims are derived from those windows. The problem is that skin runs on twelve-week clocks, sometimes longer. The skinimalism argument only makes sense if the products themselves are built for that longer arc, which means the testing has to match.
The contrarian position: we don’t track launches
Most direct-to-consumer skincare brands measure themselves on launch cadence, average order value, and repurchase frequency. We pay attention to repurchase. The other two we treat as anti-metrics. A higher AOV usually means the customer is buying more than they need. A faster launch cadence usually means we are shipping things that don’t deserve to ship.
This is a worse business in the short term. It is a better one over five years, in my honest read. The customer who buys three products and reuses them for two years is more valuable to us, and to themselves, than the customer who buys seven products in a season and abandons four.
What slow skincare is not
It is not minimalism for aesthetic reasons. It is not anti-active. It is not the rejection of innovation. The Microbiome Glow Serum uses postbiotics that did not exist as cosmetically viable ingredients five years ago. The BioCell line uses PDRN, a regenerative biotech ingredient that is genuinely new. Slow is about cadence and conviction, not about refusing the science.
It is also not the rejection of pleasure. A routine you actually enjoy using is a routine you actually use. The pleasure is in the consistency, not in the novelty hit of unboxing.
What this means for the next eighteen months
One product is in late-stage testing. Whether it ships in 2026 or 2027 depends on the twelve-week trial currently running, not on the calendar. We have skipped two seasonal collections that our retail partners would have preferred we make. Our newsletter has occasionally mentioned products we were testing, then quietly stopped mentioning them when they didn’t clear the bar. That is the version of transparency we can defend.
If the rule of the industry is move fast and ship more, our rule is the opposite. Move slowly. Ship less. Be useful longer. That’s the whole philosophy.
FAQ
Will Elelaf ever expand the line? Yes, slowly. The roadmap has space for a cleanser and a treatment serum. Neither is imminent.
Why no toner, no essence, no eye cream? Most readers don’t need them. The slow skincare manifesto walks through the subtraction logic.
Are you ever tempted to launch a viral product? Often. We have an internal rule that any product idea has to survive a two-week cooling-off period before formulation starts. Most don’t.
How do you know slow skincare actually works? Twelve-week panel data on our own line, plus the dermatology literature on consistency. The numbers are not subtle.
What if a competitor launches something genuinely better? We say so. Editorial doesn’t pretend our line is the only line that works.
Where can I read more philosophy? The skinimalism tag collects every piece on the same theme.
Sources
Farris PK et al. Long-term cosmeceutical efficacy trials. Journal of Cosmetic Dermatology, 2019. AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology, position statement on routine simplification, 2024. Elelaf internal product roadmap, 2024 to 2026.